138 related articles for article (PubMed ID: 23299960)
21. Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
Duffy N; Walker P; Diamantea F; Calverley PM; Davies L
Thorax; 2005 Sep; 60(9):713-7. PubMed ID: 15939732
[TBL] [Abstract][Full Text] [Related]
22. The role of domiciliary nebulizers in managing patients with severe COPD.
Eiser N; Angus K; McHale S
Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
[TBL] [Abstract][Full Text] [Related]
23. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
Wouters EF; Postma DS; Fokkens B; Hop WC; Prins J; Kuipers AF; Pasma HR; Hensing CA; Creutzberg EC;
Thorax; 2005 Jun; 60(6):480-7. PubMed ID: 15923248
[TBL] [Abstract][Full Text] [Related]
24. Magnesium sulfate in exacerbations of chronic obstructive pulmonary disease.
Skorodin MS; Tenholder MF; Yetter B; Owen KA; Waller RF; Khandelwahl S; Maki K; Rohail T; D'Alfonso N
Arch Intern Med; 1995 Mar; 155(5):496-500. PubMed ID: 7864705
[TBL] [Abstract][Full Text] [Related]
25. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
[TBL] [Abstract][Full Text] [Related]
26. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children.
Browne GJ; Penna AS; Phung X; Soo M
Lancet; 1997 Feb; 349(9048):301-5. PubMed ID: 9024371
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B
Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
[TBL] [Abstract][Full Text] [Related]
28. Walking exercise response to bronchodilation in mild COPD: a randomized trial.
Gagnon P; Saey D; Provencher S; Milot J; Bourbeau J; Tan WC; Martel S; Maltais F
Respir Med; 2012 Dec; 106(12):1695-705. PubMed ID: 22999808
[TBL] [Abstract][Full Text] [Related]
29. IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial.
Silverman RA; Osborn H; Runge J; Gallagher EJ; Chiang W; Feldman J; Gaeta T; Freeman K; Levin B; Mancherje N; Scharf S;
Chest; 2002 Aug; 122(2):489-97. PubMed ID: 12171821
[TBL] [Abstract][Full Text] [Related]
30. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
Lindberg A; Szalai Z; Pullerits T; Radeczky E
Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
[TBL] [Abstract][Full Text] [Related]
31. Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial.
Bardsley G; Pilcher J; McKinstry S; Shirtcliffe P; Berry J; Fingleton J; Weatherall M; Beasley R
BMC Pulm Med; 2018 Oct; 18(1):157. PubMed ID: 30285695
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.
Zuwallack R; De Salvo MC; Kaelin T; Bateman ED; Park CS; Abrahams R; Fakih F; Sachs P; Pudi K; Zhao Y; Wood CC;
Respir Med; 2010 Aug; 104(8):1179-88. PubMed ID: 20172704
[TBL] [Abstract][Full Text] [Related]
34. Beclomethasone/formoterol in the management of COPD: a randomised controlled trial.
Calverley PM; Kuna P; Monsó E; Costantini M; Petruzzelli S; Sergio F; Varoli G; Papi A; Brusasco V
Respir Med; 2010 Dec; 104(12):1858-68. PubMed ID: 20965712
[TBL] [Abstract][Full Text] [Related]
35. Formoterol Turbuhaler as reliever medication in patients with acute asthma.
Rubinfeld AR; Scicchitano R; Hunt A; Thompson PJ; Van Nooten A; Selroos O
Eur Respir J; 2006 Apr; 27(4):735-41. PubMed ID: 16455838
[TBL] [Abstract][Full Text] [Related]
36. Magnesium sulfate as a vehicle for nebulized salbutamol in acute asthma.
Nannini LJ; Pendino JC; Corna RA; Mannarino S; Quispe R
Am J Med; 2000 Feb; 108(3):193-7. PubMed ID: 10723972
[TBL] [Abstract][Full Text] [Related]
37. Intravenous magnesium sulfate as an adjunct in the treatment of acute asthma.
Bloch H; Silverman R; Mancherje N; Grant S; Jagminas L; Scharf SM
Chest; 1995 Jun; 107(6):1576-81. PubMed ID: 7781349
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease].
Zheng JP; Kang J; Cai BQ; Zhou X; Cao ZL; Bai CX; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):363-7. PubMed ID: 17045014
[TBL] [Abstract][Full Text] [Related]
39. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
Balkissoon R; Make B
COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
[TBL] [Abstract][Full Text] [Related]
40. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.
Vestbo J; Pauwels R; Anderson JA; Jones P; Calverley P;
Thorax; 2005 Apr; 60(4):301-4. PubMed ID: 15790985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]